MGNet: Defining a Treatment-Responsive Biomarker for Corticosteroid Therapy in Myasthenia Gravis

Nov 14, 2023 · 1m 42s
MGNet: Defining a Treatment-Responsive Biomarker for Corticosteroid Therapy in Myasthenia Gravis
Description

New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal PLOS One on October 10, 2023, titled "Serum metabolomics...

show more
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal PLOS One on October 10, 2023, titled "Serum metabolomics of treatment response in myasthenia gravis."

Read the paper here: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0287654

Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
show less
Information
Author RDCRN
Organization RDCRN
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search